Investor Relations

Wandelanleihen

Convertible Bond

Contact: Dr. Ulrich Wandel
ulrich.wandel@shop-apotheke.com

Convertible Bond 2018/23

SHOP APOTHEKE EUROPE N.V. issued unsecured, non-subordinated convertible bonds on 12 April 2018 and on 10 April 2019. This instrument allows longer-term financing at attractive conditions and is an interesting investment opportunity for investors.

Under the terms of the bonds, the Company may redeem the convertible bonds at their principal amount (plus accrued interest not yet paid) at any time (i) on or after May 30, 2021 if the price of the Company's shares exceeds 130% of the then applicable conversion price during a specified period or (ii) if 15 % or less of the total principal amount of the convertible bonds is outstanding.

Unless previously repaid or purchased and cancelled, the convertible bonds will be converted into shares at the option of the holder. Instead of the delivery of shares, (partial) cash payment may also be made under certain conditions.

Basic Information

  • WKN A19Y07
  • ISIN DE000A19Y072
  • Issuer SHOP APOTHEKE EUROPE N.V.
  • Stock exchange segment OTC
  • Stock exchanges Frankfurt, Berlin and Stuttgart
  • Listing continuous auction
  • Issue volume EUR 75 million (2018) + EUR 60 Mio. (2019)
  • Denomination EUR 100,000.00
  • Issue price 100%
  • Coupon 4,5%
  • Interest payments semi-annually, in arrears
  • Conversion premium 25% or EUR 46.6864
  • Maturity 19.04.2023

Events

15. August 2019

Halbjahresfinanzbericht

15 August 2019

Half-year Report

14. November 2019

Zwischenmitteilung Q3

14 November 2019

Interim Statement Q3